If studies confirm a synergistic effect between ELA and genetic factors like APOE ɛ4 or FKBP5 on inflammation and cognitive decline, it could lead to targeted screening programs for individuals with both ELA history and genetic risk factors. This evidence concerns the gene APOE and Mental deterioration.